9999999997-18-000439.txt : 20180122 9999999997-18-000439.hdr.sgml : 20180122 20180122163931 ACCESSION NUMBER: 9999999997-18-000439 CONFORMED SUBMISSION TYPE: CT ORDER PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20180122 DATE AS OF CHANGE: 20180122 ACTION DATE: 20180122 RECEIVED DATE: 20180122 FILER: COMPANY DATA: COMPANY CONFORMED NAME: LEXICON PHARMACEUTICALS, INC. CENTRAL INDEX KEY: 0001062822 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 760474169 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: CT ORDER SEC ACT: 1934 Act SEC FILE NUMBER: 000-30111 FILM NUMBER: 18540219 BUSINESS ADDRESS: STREET 1: 8800 TECHNOLOGY FOREST PLACE CITY: THE WOODLANDS STATE: TX ZIP: 77381 BUSINESS PHONE: 2818633000 MAIL ADDRESS: STREET 1: 8800 TECHNOLOGY FOREST PLACE CITY: THE WOODLANDS STATE: TX ZIP: 77381 FORMER COMPANY: FORMER CONFORMED NAME: LEXICON PHARMACEUTICALS, INC./DE DATE OF NAME CHANGE: 20070426 FORMER COMPANY: FORMER CONFORMED NAME: LEXICON GENETICS INC/TX DATE OF NAME CHANGE: 20000126 CT ORDER 1 filename1.pdf begin 644 filename1.pdf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